Just look at the Testim PI and you will plainly see that Testim at the same dosage is roughly 200ng/dL less then Androgel.
[/ QUOTE ]
Now, now. You know comparing PIs is pointless and gives yourself away as an amateur in pharma. Were the patients in your PI the same as the guys in ours? Were they the same age. Was the same lab used, with the same exact testing kits? The answers to all the above is NO, and NO means outcomes are different. But you knew that. You're just hoping the docs don't.
Peace.
...we compare AndroGel's success rate at the starting dose...thanks for helping me with my sales #'s. You guys rock!!!!!
[/ QUOTE ]
Sorry, wrong again. See the above. It explains your flawed logic. Unless you're using the SAME patients, the SAME labs, the SAME RIA kits, you just CANNOT compare these two products accurately. To do so is pathetic. Your limp product has share because it was FIRST, not because it is BEST.
Hypogonadal men or hypogonadal men. All have low T. Our product shows better data regarding T levels. Testim is a wanna-be and Docs know it. Move along stinky gel rep (that is what the staff calls you when you leave).
[/ QUOTE ]
Oh, what you don't know could fill a book.
Come on goofy bastard--5% MS nationally? Do you honestly think we are really impacted by this?
[/ QUOTE ]
With regard to MS, Solvay management is clearly lying to its field sales force in order to avoid a real motivation-killer. I've seen the national reports, every one of 'em since May of 2004. You're right, Testim did have MS of 5% -- last JULY. It's more than doubled since then, I'm afraid. The plain fact is that Testim is better for patients than Androgel, and there's no getting around it when push comes to shove.
Good luck in all your future endeavors. Chumps.
When AndroGel was launched it met an unmet need. After ONE YEAR on the market AndroGel had 20% MS. Compare that to your 5-10%. Testim is a me-too, the majority of physicians see it as that and your company is struggling trying to meet the needs of customers with a half-hearted effort with your tiny sales force. Don't be proud of this MS you have--it is ONLY because of samples. BTW we will start sampling soon. Word on the street is Q3 2004-enjoy your tiny bonus for one more quarter.
[/ QUOTE ]
Most of the highest-writing docs for Testim in my territory don't store samples. Don't forget that Testim is a superior gel, so that's why they're writing it. Also keep in mind that just because Androgel was 1st in class doesn't make it the BEST in class. Our sales force is smaller than yours (about 1/4 the size), but if you look at the weekly numbers, we're twice as effective PER REP, and more motivated that you folks could ever be. Testim is our first product; we have great things in store for the near and long-term.
You've out-chumped me again, Solvay.
